minoxidil has been researched along with Hemolytic-Uremic Syndrome in 2 studies
Minoxidil: A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)
minoxidil : A pyrimidine N-oxide that is pyrimidine-2,4-diamine 3-oxide substituted by a piperidin-1-yl group at position 6.
Hemolytic-Uremic Syndrome: A syndrome that is associated with microvascular diseases of the KIDNEY, such as RENAL CORTICAL NECROSIS. It is characterized by hemolytic anemia (ANEMIA, HEMOLYTIC); THROMBOCYTOPENIA; and ACUTE RENAL FAILURE.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vavrinec, J | 1 |
Svorc, J | 1 |
Feldhoff, CM | 1 |
Bachmann, H | 1 |
2 other studies available for minoxidil and Hemolytic-Uremic Syndrome
Article | Year |
---|---|
[Treatment of hypertension in an infant with hemolytic-uremic syndrome].
Topics: Female; Hemolytic-Uremic Syndrome; Humans; Hypertension; Infant; Minoxidil; Pyrimidines | 1982 |
[Pericardial effusion during long-term treatment with minoxidil].
Topics: Child; Hemolytic-Uremic Syndrome; Humans; Male; Minoxidil; Pericardial Effusion; Pyrimidines; Recurr | 1982 |